
Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster.
The Manager, Bioanalytical Systems & Digital Enablement is responsible for coordinating global strategy, governance, and administration of bioanalytical laboratory systems and supporting digital platforms in close partnership with stakeholders.
This role combines strategic coordination with hands-on operational execution, ensuring that global laboratory systems (e.g., LIMS, ELN, instrument integration) and operational tools are effectively implemented, utilized, compliant, and continuously optimized.
Operating at the intersection of science, operations, and IT, this role:
The position serves as both a global coordinator and working leader, accountable for enabling system performance, supporting project delivery, and day-to-day operational support, while ensuring that key decisions are made collaboratively with relevant stakeholders.
Strategy, Governance, and Execution
Hands-On System Administration & Support
Integration & Data Flow
Collaboration & Cross-Site Alignment
Innovation & Continuous Improvement
Compliance & Quality
Adoption & Support Model
Celerion Values: Integrity Trust Teamwork Respect
Celerion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, genetic information, marital status, qualified protected veteran status, or disability.

Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
Our operations are strategically located in:
Lincoln, Nebraska (Corporate Headquarters)
Philadelphia, Pennsylvania
Phoenix, Arizona
Belfast, Northern Ireland,UK
Zurich, Switzerland
Vienna, Austria
Richmond, Virginia
Montreal, Quebec, Canada
For more information, visit: www.celerion.com